Abstract:Spinal muscular atrophy (SMA) is a neurodegenerative disease characterized by a varying degree of severity that correlates with the reduction of SMN protein levels. Motor neuron degeneration and skeletal muscle atrophy are hallmarks of SMA, but it is unknown whether other mechanisms contribute to the spectrum of clinical phenotypes. Here, through a combination of physiological and morphological studies in mouse models and SMA patients, we identify dysfunction and loss of proprioceptive sensory synapses as key signatures of SMA pathology. We demonstrate that SMA patients exhibit impaired proprioception, and their proprioceptive sensory synapses are dysfunctional as measured by the neurophysiological test of the Hoffmann reflex (H-reflex). We further show that loss of excitatory afferent synapses and altered potassium channel expression in SMA motor neurons are conserved pathogenic events found in both severely affected patients and mouse models. Lastly, we report that improved motor function and fatigability in ambulatory SMA patients and mouse models treated with SMN-inducing drugs correlate with increased function of sensory-motor circuits that can be accurately captured by the H-reflex assay. Thus, sensory synaptic dysfunction is a clinically relevant event in SMA, and the H-reflex is a suitable assay to monitor disease progression and treatment efficacy of motor circuit pathology.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is whether sensorimotor circuit dysfunction in spinal muscular atrophy (SMA) is a key pathological event in disease progression, and whether this dysfunction is common in mouse models and human patients. Specifically, the researchers focused on the dysfunction of proprioceptive afferent nerve synapses in SMA patients and mouse models and its impact on the disease process. In addition, the study also explored whether these dysfunctions can be used as potential targets for treating SMA, and evaluated the application value of a neurophysiological test called Hoffmann reflex (H - reflex) in monitoring disease progression and treatment effects. ### Research Background and Problems 1. **Pathological Mechanisms of SMA**: - SMA is a neurodegenerative disease caused by reduced levels of SMN protein, mainly manifested as motor neuron degeneration and skeletal muscle atrophy. - Previous studies have mainly focused on the degeneration of motor neurons, but little is known about other possible pathogenic mechanisms. 2. **Dysfunction of Sensorimotor Circuits**: - Previous studies have found that there is a dysfunction of proprioceptive afferent nerve synapses in SMA mouse models, which may lead to impaired function of motor neurons. - However, it is not clear whether these findings are applicable to human SMA patients. 3. **Application of H - reflex**: - H - reflex is a neurophysiological test that can be used to assess the functional state of sensorimotor circuits. - The researchers hope to use the H - reflex test to verify whether there is a similar dysfunction in SMA patients as in mouse models. ### Main Research Questions 1. **Is there a dysfunction of proprioceptive afferent nerve synapses in SMA patients?** - Assess the sensorimotor circuit function of SMA patients through H - reflex tests and other neurophysiological tests. - Compare the H - reflex amplitude and latency between SMA patients and normal control groups to determine the existence of dysfunction. 2. **Is the dysfunction of proprioceptive afferent nerve synapses in SMA patients related to the severity of the disease?** - Analyze the correlation between H - reflex test results and clinical scores (such as Hammersmith Functional Motor Scale Expanded, HFMSE) to assess the relationship between dysfunction and disease severity. 3. **Can existing SMN - inducing therapies improve the sensorimotor circuit function in SMA patients?** - Compare the H - reflex test results of SMA patients who have received SMN - inducing therapies (such as nusinersen) with those of untreated patients to assess the treatment effect. - Evaluate the improvement of patients in the 6 - minute walk test (6MWT) and fatigue after treatment. ### Conclusions The research results show that the dysfunction of proprioceptive afferent nerve synapses is a conserved pathological event in SMA patients and mouse models, and the H - reflex test can effectively assess this dysfunction. In addition, existing SMN - inducing therapies can partially restore the function of sensorimotor circuits, thereby improving patients' motor ability and reducing fatigue. These findings provide new perspectives and tools for the diagnosis and treatment of SMA.

Dysfunction of proprioceptive sensory synapses is a pathogenic event and therapeutic target in mice and humans with spinal muscular atrophy

Synaptic imbalance and increased inhibition impair motor function in SMA

Mitochondrial Dysfunction in Spinal Muscular Atrophy

Dysregulation of Synaptogenesis Genes Antecedes Motor Neuron Pathology in Spinal Muscular Atrophy

Targeted Stimulation of the Sensory Afferents Improves Motoneuron Function in Humans with Spinal Muscular Atrophy

A spinal muscular atrophy modifier implicates the SMN protein in SNARE complex assembly at neuromuscular synapses

Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy

Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy.

Beyond Motor Neurons in Spinal Muscular Atrophy: A Focus on Neuromuscular Junction

Abnormal fatty acid metabolism is a core component of spinal muscular atrophy

Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy

Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy

Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy

SMN deficiency induces an early non-atrophic myopathy with alterations in the contractile and excitatory coupling machinery of skeletal myofibers in the SMN∆7 mouse model of spinal muscular atrophy

Skeletal Muscle in Motor Neuron Diseases: Therapeutic Target and Delivery Route for Potential Treatments

Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment

Dysregulation of innate immune signaling in animal models of spinal muscular atrophy

Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy

Effect of E134K pathogenic mutation of SMN protein on SMN-SmD1 interaction, with implication in spinal muscular atrophy: A molecular dynamics study

Modulating the endoplasmic reticulum stress response attenuates neurodegeneration in a Caenorhabditiselegans model of spinal muscular atrophy

A large animal model of spinal muscular atrophy and correction of phenotype